Toll-like receptor-4 deficiency attenuates doxorubicin-induced cardiomyopathy in mice (Q46717362)

24 December 2017

title

Toll-like receptor-4 deficiency attenuates doxorubicin-induced cardiomyopathy in mice (English)

1 reference

24 December 2017

0 references

1 reference

7

Stefan Bereswill

1 reference

24 December 2017

6

Markus M Heimesaat

1 reference

24 December 2017

Carsten Tschöpe

12

Carsten Tschöpe

1 reference

24 December 2017

Felicitas Escher

4

Felicitas Escher

1 reference

24 December 2017

Alexander Riad

1

Alexander Riad

1 reference

24 December 2017

Dirk Westermann

5

Dirk Westermann

1 reference

24 December 2017

Stephan B Felix

9

Stephan B Felix

1 reference

24 December 2017

author name string

Sandra Bien

2

1 reference

24 December 2017

Matthias Gratz

3

1 reference

24 December 2017

Thomas Krieg

8

1 reference

24 December 2017

Heinz P Schultheiss

10

1 reference

24 December 2017

Heyo K Kroemer

11

1 reference

24 December 2017

publication date

5 March 2008

1 reference

24 December 2017

European Journal of Heart Failure

published in

1 reference

24 December 2017

volume

10

1 reference

24 December 2017

issue

3

1 reference

24 December 2017

page(s)

233-243

1 reference

24 December 2017

Progressive cardiac dysfunction in adriamycin-induced cardiomyopathy rats

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Protective effects of carvedilol against anthracycline-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Simultaneous angiotensin converting enzyme inhibition moderates ventricular dysfunction caused by doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Anthracycline-related toxicity requiring cardiac transplantation in long-term disease-free survivors with acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

NF-kappa B: ten years after

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Expansion of circulating Toll-like receptor 4-positive monocytes in patients with acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Escherichia coli LPS-induced LV dysfunction: role of toll-like receptor-4 in the adult heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Diltiazem treatment prevents diastolic heart failure in mice with familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Comparison of intravenous and pulmonary artery injections of hypertonic saline for the assessment of conductance catheter parallel conductance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Protective role of angiopoietin-1 in endotoxic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

The role of endothelin in hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

The endothelin receptor blocker bosentan inhibits doxorubicin-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Status of myocardial antioxidants in ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and in vivo studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Cell death: critical control points

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Mitochondrial carrier homolog 2: a clue to cracking the BCL-2 family riddle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.004

10.1016/J.EJHEART.2008.01.004

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

18321777

1 reference

24 December 2017